Windtree files prospectus supplement for up to $27.2M stock issuance to Seven Knots

WINDTREE THERAPEUTICS INC /DE/

Registered up to $27,243,504 in common shares for issuance and resale under existing equity line with Seven Knots.
As of Oct 25, 2024, issued 5,499,273 shares for $7,756,496 gross proceeds under the Purchase Agreement.
Redeemed 1,499 Series C Preferred Shares for $2.3M using proceeds from equity line sales.
Obtained stockholder approval at Sept 2024 annual meeting to exceed the Nasdaq Exchange Cap.
Based on 8,746,128 shares outstanding, no longer subject to Form S-3 one-third float limit until next 10-K.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.